Revision: Jan. 30, 2017, 12:20 p.m.
HB 197 - AS INTRODUCED
2017 SESSION
17-0639
01/10
HOUSE BILL 197
SPONSORS: Rep. Cushing, Rock. 21; Rep. Umberger, Carr. 2; Rep. Butler, Carr. 7; Rep. Abel, Graf. 13; Sen. Bradley, Dist 3; Sen. Fuller Clark, Dist 21
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
This bill adds myelitis disorder or disease to the qualifying medical conditions under therapeutic use of cannabis.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
17-0639
01/10
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Seventeen
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Use of Cannabis for Therapeutic Purposes; Definitions. Amend RSA 126-X:1, IX(a)(1) to read as follows:
(1) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C currently receiving antiviral treatment, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, myelitis disorder or disease, or one or more injuries that significantly interferes with daily activities as documented by the patient's provider; and
2 Effective Date. This act shall take effect 60 days after its passage.